Immediate Impact

11 hit
Sub-graph 1 of 6

Citing Papers

Rational Development of LEA29Y (belatacept), a High-Affinity Variant of CTLA4-Ig with Potent Immunosuppressive Properties
2005 Hit
CD40/CD154 Interactions at the Interface of Tolerance and Immunity
2004 Hit

Works of Yinchen Dong being referenced

CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates
1997 Hit
Rankless by CCL
2026